We’ve never talked about True Nature Holdings, Inc. (OTCMKTS:TNTY) here on Jounral Transcript before today, so to give a bit of background, the company describes itself as being on a mission to unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals.
In recent sessions, the stock had been trading as low as the mid-.20’s and looks to finish the week strong as it has cracked the .40-mark, and is bringing further attention to itself with the launch of what it is calling a Targeted Community Health Initiative.
True Nature Holdings, Inc. (OTCMKTS:TNTY)’s new initiative is aimed supporting the need for lower cost pharmaceuticals within the medically underserved small town and rural marketplaces. The Company intends to form a joint venture for-profit subsidiary; True Nature Community Health, Inc., which will be owned 51% percent by the public company, and 49% by a newly formed not-for-profit entity; The True Nature Community Health Foundation.
“The individuals who wrote the business plan for our compounding pharmacy roll-up include senior executives who have extensive experience and in-depth knowledge within the not-for-profit space. We have always intended to drive lower cost pharmaceutical solutions through increased distribution of specialized formulations, and to develop a catalog of intellectual properties that could be monetized through both conventional retail distribution and new strategies aimed at the medically underserved populations in lower-income, small town, and rural communities,” explained Dr. Jordan Balencic, Chairman of The Board of Directors.
He continued, “The True Nature Community Health subsidiary will become the conduit for distribution of both our proprietary and other non-proprietary products to Federally Qualified Health Centers (FQHCs) and Rural Health Clinics as well as critical access hospitals, while The True Nature Community Health Foundation will focus its efforts on advancing patient health, education, and innovative service delivery solutions required to address the healthcare needs of these underserved and aging populations. The result is to make a significant, scalable social impact while driving additional revenue streams and innovating in the social enterprise and compounding pharmaceutical space.”
The Company will provide reduced cost pricing to the Foundation and will likely use a subscriber model to allow widespread access, granting the reduced pricing to qualified participants and with online, lower cost access. The reduced pricing will reflect volume pricing commitments and other benefits from a captive distribution model. The federal funding model available under Section 330 is directly aligned with the mission of the Company, and can be found at the link, below and with this summary text:
Section 330 of the Public Health Service Act [42 U.S.C. 254b] Sec. 330(b) (3) Medically underserved populations. • (A) In general. The term “medically underserved population” means the population of an urban or rural area designated by the Secretary as an area with a shortage of personal health services or a population group designated by the Secretary as having a shortage of such services. https://www.bphc.hrsa.gov/programrequirements/index.html
When asked about the prioritization of this effort relative to the Company’s other acquisitions, Dr. Balencic stated, “I expect to personally spearhead this effort, while our executive management team focuses on closing our pending acquisitions. I expect the top three (3) acquisitions to move into completion phase and license transfer processing soon, while the community healthcare formation runs in parallel. This should all come online about the same time, during the 3rd quarter of 2017. This is all very exciting news for us and our shareholders.” (Source: Marketwired)
With the company expecting the completion of its acquisitions in the coming months, as well as the new initiative and the boost we’re seeing on the chart, we’re going to want to begin to follow the TNTY story more closely. Stay locked to Journal Transcript for updates, and we’ll deliver important developments on TNTY as they unfold.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:
The Next Big Thing In Biotech?https://journaltranscript.com
Get our top rated alerts on the biotech sector
A new field of medicine needs attentionhttps://journaltranscript.com
Here are the reasons to invest in CMXC
Traders Need To Know This Nowhttps://journaltranscript.com
WallStreet is loading up on this stock. Find out why